
Intrinsic Medicine (formerly Lupa Bio) is a preclinical-stage biotechnology company developing synthetic biology-manufactured HiMO molecules as novel therapeutics targeting the gut-brain axis and metabolic diseases. Founded in 2018 by Alexander Martinez and Jason Ferrone, the company leverages microbiome science to develop next-generation treatments. Its platform focuses on creating precision medicines derived from human milk oligosaccharides.